Furthermore, a limitation of this study involves the lack of heterogeneity found in the in vitro studies and, hence, why future studies may be necessary to elaborate on the nature of BUD31 expression in different molecular signatures across a variety of different tumor cell types. Here, BUD31 is linked to neoplasm.